Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.02
21.11.23
€1.00
21.11.24
0.39%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
HelloFresh SE

Start price
Target price
Perf. (%)
€14.99
21.11.23
€18.00
21.11.24
-3.84%
29.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
BT Group plc ADR

Start price
Target price
Perf. (%)
€10.00
19.11.23
€2.00
01.01.25
-
23.11.23

buy
HelloFresh SE

Start price
Target price
Perf. (%)
€16.36
17.11.23
€18.00
17.11.24
-8.35%
21.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€0.96
12.11.23
-
12.11.24
8.88%
24.11.23

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.88
11.11.23
-
11.11.24
-
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Aytu Biopharma Inc.

Start price
Target price
Perf. (%)
€2.72
07.11.23
€5.30
07.12.23
-9.56%
13.11.23

Could be very worthwhile Investment >20% year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.81
05.11.23
-
05.11.24
15.43%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.20
31.10.23
€1.00
31.10.24
-15.47%
21.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ayr Wellness Inc.

Start price
Target price
Perf. (%)
€1.12
30.10.23
-
30.10.24
145.11%
19.01.24

Risky Investment
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.86
29.10.23
€2.80
30.09.25
-
30.10.23

Could be very worthwhile Investment >20% year
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€1.51
23.10.23
-
23.10.24
-23.18%
28.10.23

Could be worthwhile Investment >10% per year
buy
Oremex Silver

Start price
Target price
Perf. (%)
€0.005
18.10.23
€0.000
18.10.24
22.22%
24.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.32
16.10.23
-
16.10.24
34.48%
11.12.23

Probably not worthwhile Investment
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.23
16.10.23
-
16.10.24
3.45%
28.10.23

Could be very worthwhile Investment >20% year
buy
Lyxor Ucits Etf Sicav (lux) - S&p 500 Vix Fut. Enh. Roll

Start price
Target price
Perf. (%)
€1.69
10.10.23
-
10.10.24
-24.00%
15.02.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.21
09.10.23
-
09.10.24
1.99%
15.10.23

Could be worthwhile Investment >10% per year
Microbot Medical Inc

Start price
Target price
Perf. (%)
€1.25
04.10.23
-
04.10.24
-8.80%
11.12.23

Probably not worthwhile Investment
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
03.10.23
-
03.10.24
6.62%
04.10.23

buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.28
01.10.23
€2.00
30.09.25
14.84%
29.10.23

Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.64
30.09.23
€1.00
30.09.24
-9.76%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Gulf Resources Inc.

Start price
Target price
Perf. (%)
€1.65
28.09.23
-
28.09.24
-7.88%
24.10.23

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.47
26.09.23
-
26.09.24
-26.87%
15.10.23

Could be very worthwhile Investment >20% year
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.41
21.09.23
-
21.09.26
-14.23%
13.10.23

Could be very worthwhile Investment >20% year